NeoGenomics, Inc. (NASDAQ:NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology (ASCO) conference in Chicago, May 31–June 4 (booth #31093).
Old Second Bancorp Q3 EPS $0.43 Up From $0.29 YoY
Old Second Bancorp (NASDAQ:OSBC) reported quarterly earnings of $0.43 per share. This is a 48.28 percent increase over earnings of $0.29 per share from the same period last year.
